4.5 Review

Two-tier transcriptional control of oligodendrocyte differentiation

Journal

CURRENT OPINION IN NEUROBIOLOGY
Volume 19, Issue 5, Pages 479-485

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.conb.2009.08.004

Keywords

-

Categories

Funding

  1. Wellcome Trust
  2. UK Medical Research Council
  3. National Multiple Sclerosis Society
  4. National Institutes of Health [R01NS42925, RO1NS52738, 1R01NS059893-01A1]
  5. Medical Research Council [G9708005, G0800575] Funding Source: researchfish
  6. MRC [G9708005, G0800575] Funding Source: UKRI
  7. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925, R01NS059893, R01NS052738] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Oligodendrocytes (OLs) are the myelin-forming cells of the central nervous system (CNS). They differentiate from proliferative OL precursor cells that migrate from the embryonic neuroepithelium throughout the developing CNS before associating with axons and elaborating myelin. Recent research into the regulation of OL differentiation has uncovered a two-stage mechanism of transcriptional control that combines epigenetic repression of transcriptional inhibitors with direct transcriptional activation of myelin genes. This 'two-pronged' approach creates a fail-safe system of genetic control to ensure orderly and unambiguous expression of the myelination program during development and during repair of demyelinated lesions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available